Stifel, RBC are bookrunners; Ladenberg Thalmann, Raymond James assist
By Toni Weeks
San Luis Obispo, Calif., April 14 - TransEnterix, Inc. priced its $50 million public sale of common stock with a 30-day, $7.5 million greenshoe, according to a press release.
The company will sell 12.5 million shares at $4.00 each.
Stifel, Nicolaus & Co. Inc. and RBC Capital Markets LLC are the joint bookrunning managers; Ladenberg Thalmann & Co. and Raymond James Financial Inc. are the co-managers.
Settlement is expected April 21.
Proceeds will be used for research and development, sales, marketing and commercialization related to the SurgiBot System, working capital and other general corporate purposes.
The Morrisville, N.C., medical device company develops flexible instruments and robotics to improve minimally invasive surgery. The company's common stock will begin trading on the NYSE MKT under the symbol "TRXC" on Tuesday.
| Issuer: | TransEnterix, Inc.
|
| Issue: | Common shares
|
| Amount: | $50 million
|
| Greenshoe: | $7.5 million
|
| Shares: | 12.5 million
|
| Price: | $4.00
|
| Warrants: | No
|
| Bookrunners: | Stifel, Nicolaus & Co. Inc. and RBC Capital Markets LLC
|
| Co-managers: | Ladenberg Thalmann & Co. and Raymond James Financial Inc.
|
| Announcement date: | April 2
|
| Pricing date: | April 14
|
| Settlement date: | April 21
|
| Stock symbol: | NYSE: TRXC
|
| Market capitalization: | $420.15 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
